Published in Nat Rev Cardiol on September 20, 2011
A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med (2011) 3.76
Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest. N Engl J Med (2011) 2.45
Characterization of mice lacking the gene for cholecystokinin. Am J Physiol Regul Integr Comp Physiol (2007) 1.09
Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts. J Neuroimmunol (2007) 1.01
Lipids. Antibodies against PCSK9--a new era of therapy. Nat Rev Cardiol (2012) 0.89
Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology (2010) 0.89
Public health: Health risks of physical inactivity similar to smoking. Nat Rev Cardiol (2012) 0.88
Stem cells. Could it be TIME to abandon BMCs? Nat Rev Cardiol (2012) 0.87
Tumor O(6)-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib. Clin Cancer Res (2010) 0.85
Children are key to CVD prevention. Nat Rev Cardiol (2010) 0.79
Acute coronary syndromes: ACS in developing countries--insights from the ACCESS registry. Nat Rev Cardiol (2011) 0.78
Public health: Value of echocardiographic screening for RHD in Ugandan children. Nat Rev Cardiol (2012) 0.78
Prevention: Neuropsychiatric adverse effects signal the end of the line for rimonabant. Nat Rev Cardiol (2010) 0.77
Erectile dysfunction and CVD. Nat Rev Cardiol (2010) 0.77
Poor health literacy: a 'hidden' risk factor. Nat Rev Cardiol (2010) 0.77
Valvular disease: TAVR outcomes maintained 2-years after the PARTNER trial. Nat Rev Cardiol (2012) 0.75
Atrial fibrillation. First-line catheter ablation therapy--too much too soon? Nat Rev Cardiol (2012) 0.75
Congenital heart conditions. Closure of PFO--more questions than answers. Nat Rev Cardiol (2013) 0.75
Prevention: Low-dose omega-3 supplementation--no beneficial effect in patients with prior MI. Nat Rev Cardiol (2010) 0.75
Heart failure: Registry data reveal disparities in care. Nat Rev Cardiol (2012) 0.75
Vascular disease: Atherosclerosis unravelled--clues from ancient civilizations. Nat Rev Cardiol (2013) 0.75
Arrhythmias. A new hybrid ablation technique for AF. Nat Rev Cardiol (2011) 0.75
Coronary artery disease: individualize care for multivessel CAD. Nat Rev Cardiol (2013) 0.75
Heart failure: Placing an EMPHASIS on the mineralocorticoid receptor--benefit of eplerenone in mild HF. Nat Rev Cardiol (2011) 0.75
Risk factors: Cigarette smoking increases the risk of coronary heart disease in women more than in men. Nat Rev Cardiol (2011) 0.75
Acute coronary syndromes: Abciximab delivered to the MI lesion reduces infarct size. Nat Rev Cardiol (2012) 0.75
Advanced age should not be a contraindication for cardiac resynchronization therapy. Nat Rev Cardiol (2012) 0.75
Device therapy: Reuse of ICDs in developing countries--'proof of concept' data published. Nat Rev Cardiol (2012) 0.75
Risk factors: Eating for two? Maternal weight gain and offspring cardiovascular risk. Nat Rev Cardiol (2010) 0.75
Acute coronary syndromes: Is early abciximab beneficial in STEMI? Nat Rev Cardiol (2012) 0.75
Interventional cardiology: Examining the issues related to PCI without on-site surgical back-up. Nat Rev Cardiol (2012) 0.75
Risk factors: Everything in moderation—binge drinking increases CVD risk. Nat Rev Cardiol (2011) 0.75
Thrombosis: Choose thigh-length compression stockings for DVT prevention. Nat Rev Cardiol (2010) 0.75
Atrial fibrillation: Is dabigatran cost-effective compared with warfarin in patients with AF? Nat Rev Cardiol (2011) 0.75
Hypertension: Understanding patients' perceptions could improve therapy. Nat Rev Cardiol (2012) 0.75
Interventional cardiology: Cormorbidity index could help select elderly patients for SES implantation. Nat Rev Cardiol (2011) 0.75
The dual challenge of BP control. Nat Rev Cardiol (2009) 0.75
Arrhythmias: Widespread use of public-access AEDs improves survival after cardiac arrest. Nat Rev Cardiol (2010) 0.75
Atrial fibrillation: new-onset AF in women--an independent risk factor or a 'canary in a coal mine'? Nat Rev Cardiol (2011) 0.75
Arrhythmias: CPAP with ablation reduces AF in OSA. Nat Rev Cardiol (2013) 0.75
Surgery: COPPS trial heralds new indication for colchicine. Nat Rev Cardiol (2010) 0.75
Antiplatelet therapy: Surgery should not interrupt treatment. Nat Rev Cardiol (2011) 0.75
Cardiomyopathies: CMR sheds new light on the clinical profile of stress cardiomyopathy. Nat Rev Cardiol (2011) 0.75
Coronary artery disease: CABG is preferable to PCI for complex left-main or three-vessel disease. Nat Rev Cardiol (2011) 0.75
Prevention. Cost-effectiveness of cardiovascular disease prevention and management in the developing world. Nat Rev Cardiol (2012) 0.75
Heart failure: Registry data highlight global differences in care for HF-PEF. Nat Rev Cardiol (2011) 0.75
Erectile dysfunction and CVD. Nat Rev Urol (2010) 0.75
Prevention: Fibrates reduce risk of coronary events. Nat Rev Cardiol (2010) 0.75
Prevention: the benefits of a Mediterranean diet. Nat Rev Cardiol (2013) 0.75
Arrhythmias: apixaban triumphs over aspirin for stroke prevention in patients with atrial fibrillation. Nat Rev Cardiol (2011) 0.75
Surgery: No benefit of cerebral perfusion over hypothermia in pulmonary endarterectomy. Nat Rev Cardiol (2011) 0.75
Risk factors: Fried foods not linked to CHD in Spain. Nat Rev Cardiol (2012) 0.75
Hypertension: Careful monitoring of kidney function is needed in patients with hypertension. Nat Rev Cardiol (2010) 0.75
Eptifibatide is noninferior to abciximab: implications for clinical practice. Nat Rev Cardiol (2010) 0.75
Cyclosporine after MI. Nat Rev Cardiol (2010) 0.75
Prevention: Statins go beyond cardioprotection. Nat Rev Cardiol (2011) 0.75
Atrial fibrillation: Could subclinical AF be a missing link in the etiology of cryptogenic stroke? Nat Rev Cardiol (2012) 0.75
Heart failure: TITAN trial results published. Nat Rev Cardiol (2012) 0.75
Imaging cerebral microemboli during TAVI. Nat Rev Cardiol (2012) 0.75
Digital technology in cardiac care. Nat Rev Cardiol (2010) 0.75
Arrhythmias: home AEDs-a question of rhythm? Nat Rev Cardiol (2011) 0.75
Surgery: radial artery grafts not superior to saphenous vein grafts at 1 year after CABG surgery. Nat Rev Cardiol (2011) 0.75
Thrombosis: Selective D-dimer testing improves efficiency of DVT diagnosis. Nat Rev Cardiol (2013) 0.75
Valvular disease: the UK TAVI experience: insights from the 'real world'. Nat Rev Cardiol (2011) 0.75
Diagnosis. Novel protocol for risk assessment of patients with chest pain. Nat Rev Cardiol (2011) 0.75
Heart failure: poor health literacy increases mortality. Nat Rev Cardiol (2011) 0.75
Valvular disease: PARTNER cohort A-TAVR is an option for operable severe aortic stenosis. Nat Rev Cardiol (2011) 0.75
Heart failure. Promising data for serelaxin. Nat Rev Cardiol (2012) 0.75
Interventional cardiology: Radial access improves PCI outcomes. Nat Rev Cardiol (2012) 0.75
Interventional cardiology: New insights into PCI for chronic total occlusion. Nat Rev Cardiol (2012) 0.75
Novel omega-3 agent reduces residually high triglyceride levels in patients treated with statins. Nat Rev Cardiol (2012) 0.75
Vascular disease: aortic plaque--dual therapy for a heterogeneous disease. Nat Rev Cardiol (2013) 0.75
Atrial fibrillation: First head-to-head comparison of catheter and surgical ablation for drug-refractory AF. Nat Rev Cardiol (2011) 0.75
Air pollution reduces EPC levels. Nat Rev Cardiol (2010) 0.75
Diabetes: olmesartan slows microalbuminuria. Nat Rev Cardiol (2011) 0.75
Interventional cardiology. Radial artery access--a RIVAL to the femoral approach. Nat Rev Cardiol (2011) 0.75
Device therapy: avoid apical lead position in CRT. Nat Rev Cardiol (2011) 0.75
Congenital heart conditions: Clear benefits of pulse oximetry in neonates--one small step to improving postnatal cardiac care. Nat Rev Cardiol (2011) 0.75
Risk factors: Pregnancy loss increases risk of MI. Nat Rev Cardiol (2011) 0.75
Arrhythmias: RAAS inhibition in atrial fibrillation-one strike, but not out? Nat Rev Cardiol (2011) 0.75
Lipids: Cardioprotective effects of HDL cholesterol called into question. Nat Rev Cardiol (2012) 0.75
Obesity: long-term benefits of gastric bypass on cardiac structure and function. Nat Rev Cardiol (2011) 0.75
Prevention: Small reductions in risk factors equal big savings in health-care costs. Nat Rev Cardiol (2011) 0.75
Arrhythmias. Ablation of atrioventricular nodal re-entrant tachycardia is safe and effective in the elderly. Nat Rev Cardiol (2011) 0.75
Arrhythmias: High-dose, prescription omega-3 fatty acids do not prevent recurrent AF. Nat Rev Cardiol (2011) 0.75
Coronary heart disease: New hope for CETP inhibitors. Nat Rev Cardiol (2011) 0.75
Hypertension: AT1 autoantibodies and response to therapy. Nat Rev Cardiol (2011) 0.75
Antiplatelet therapy: Making the SWAP from clopidrogrel to prasugrel. Nat Rev Cardiol (2010) 0.75
Stroke: parental stroke is an independent risk factor for stroke and transient ischemic attack. Nat Rev Cardiol (2010) 0.75
Atrial fibrillation: RF needle improves septal puncture. Nat Rev Cardiol (2011) 0.75
Acute coronary syndromes: Air pollution and survival after MI. Nat Rev Cardiol (2013) 0.75
Prevention. Statin therapy--if at first you don't succeed... Nat Rev Cardiol (2013) 0.75
Interventional cardiology: Antithrombotic therapy for PCI--getting the balance right. Nat Rev Cardiol (2013) 0.75
Prevention. Low adoption of healthy lifestyles. Nat Rev Cardiol (2013) 0.75
Device therapy: Clinical sequelae of cardiac device-related endocarditis. Nat Rev Cardiol (2012) 0.75
Thrombosis: An effective therapy for leg SVT. Nat Rev Cardiol (2010) 0.75
Atrial fibrillation: HAS-BLED--a new risk score to predict bleeding in patients with AF. Nat Rev Cardiol (2011) 0.75
Atrial fibrillation: Is short-term antiarrhythmic therapy an option? Nat Rev Cardiol (2012) 0.75
Atrial fibrillation: Strict rate control unnecessary in AF? Nat Rev Cardiol (2011) 0.75
Vascular disease. Corticosteroid therapy improves outcomes for Japanese children with Kawasaki disease. Nat Rev Cardiol (2012) 0.75
Elevated systolic blood pressure in middle age is associated with late-life dementia. Nat Rev Cardiol (2010) 0.75
Prevention: could flu vaccine join the secondary prevention armamentarium for ACS? Nat Rev Cardiol (2011) 0.75